Condition: Obesity · Overweight · Type 2 Diabetes Mellitus (T2DM) · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA) being developed for chronic weight management, as an adjunct to a reduced-calorie diet and increased physical activity in participants without Type 2 diabetes mellitus (T2DM) who have obesity or overweight with at least one weight-related comorbidity, and in participants with T2DM who have obesity or overweight.
This description comes directly from the study's public registry record.
Reference Study ID Number: YC46401 https://forpatients.roche.com No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Yan'an University Xianyang Hospital | Xianyang, Shaanxi, China | Recruiting |
| The First Affiliated Hospital of Ningbo University(Ningbo First Hospital) | Ningbo, Zhejiang, China | Recruiting |
| Peking University People's Hospital | Beijing, China | Recruiting |
| Jinan Central Hospital | Jinan, China | Recruiting |
| Hebei Petro China Central Hospital | Langfang, China | Recruiting |
| Luoyang Third People's Hospital | Luoyang, China | Recruiting |
| Shanghai Tenth People's Hospital | Shanghai, China | Recruiting |
| Shanghai East Hospital | Shanghai, China | Recruiting |
| Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
| Shanghai Fifth People's Hospital Affiliated to Fudan University | Shanghai, China | Recruiting |
| Hebei Medical University - The Second Hospital | Shijiazhuang, China | Recruiting |
| Zibo Municipal Hospital. | Zibo, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07670416